SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-022041
Filing Date
2020-11-19
Accepted
2020-11-19 17:01:27
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 893213
2 ex31-1.htm EX-31.1 18134
3 ex31-2.htm EX-31.2 17851
4 ex32-1.htm EX-32.1 7326
5 ex32-2.htm EX-32.2 7230
  Complete submission text file 0001493152-20-022041.txt   3986215

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20200930.xml EX-101.INS 606465
7 XBRL SCHEMA FILE prph-20200930.xsd EX-101.SCH 58444
8 XBRL CALCULATION FILE prph-20200930_cal.xml EX-101.CAL 56977
9 XBRL DEFINITION FILE prph-20200930_def.xml EX-101.DEF 175952
10 XBRL LABEL FILE prph-20200930_lab.xml EX-101.LAB 366744
11 XBRL PRESENTATION FILE prph-20200930_pre.xml EX-101.PRE 248360
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 201329475
SIC: 2834 Pharmaceutical Preparations